Gestione dell'anemia e utilizzo di ESA secondo i dati dello studio DOPPS.

Locatelli F. , Pisoni R.L. , Akizawa T. , Cruz J.M. , De Oreo P. , Lamiere N. , Held P.J. . Anemia management for hemodialysis patients: Guideline and DOPPS Findings. AJKD 2004; 44(Suppl 2): S27–33.

Locatelli F. , Pisoni R.L. , Compe C. . Anemia in hemodialysis Countries: Association with Morbidity and Mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). ND&T 2004; 19(1): 121–32.

Pisoni R.L. , Bragg-Gresham J.L. , Young E.W. . Anemia Management and Outcomes from 12 Centres in the DOPPS study. AJKD 2004; 44(1): 94–111.

Pisoni R.L. . Erytropoietin Therapy in Europe: Results from the DOPPS - Hemodialyis technology- Contribution to Nephrology, Ronco G. , La Greca G. , eds Basel, Karger, 2002; 137: 396–402.

MacDonald I. . Evolution of iron compound over the last century, JRC 2009; 35(Suppl 2): 8–13.

Jenkins K. . Creative iron management, a practical guide. JRC 2009; 35(Suppl 2): 32–5.

Jenkins K. , Anemia in C.K.D. . In Thomas N. editor, Advaced Renal Nursing, Chapter 3. Blackwell Publishing, London 2005.

Pugh-Clark K. , Cooper L. , Turner J. , Fermin J. . An evidence-based approach to anemia management in predialysis. Chronic Kideny Disease, JRC 35; (Suppl 2): 29–31.

McDonald J. , Forward, JRC 2009; 35(Suppl 2): 1.